United States Food and Drug Administration
PulseAugur coverage of United States Food and Drug Administration — every cluster mentioning United States Food and Drug Administration across labs, papers, and developer communities, ranked by signal.
- subsidiary of United States Department of Health and Human Services 100%
- parent of Center for Drug Evaluation and Research 100%
- employed by Kyle Diamantas 90%
- developed by Revolution Medicines (United States) 90%
- employed by Marty Makary 70%
- other Supreme Court of the United States 60%
- affiliated with Joe Biden Administration cabinet 60%
- affiliated with United States Centers for Disease Control and Prevention 60%
- affiliated with Biden Administration 60%
- affiliated with European Medicines Agency 60%
- other Marty Makary 50%
- other Eli Lilly and Company 50%
- 2026-06-24 regulatory The FDA reached a compromise with Whoop Wearable regarding blood pressure monitoring, avoiding a shutdown of related features. source
- 2026-06-15 regulatory The FDA released draft guidance on AI in medical devices. source
- 2026-06-12 regulatory The FDA announced the first real-time clinical trial data system, enabled by widespread AI adoption. source
- 2026-06-12 regulatory The FDA authorized fruit-flavored e-cigarettes from Glas Inc., despite questions about their efficacy in helping smokers quit. source
- 2026-06-11 regulatory Anthropic CEO Dario Amodei proposed that the FDA should expedite its review process for AI-designed drugs. source
- 2026-05-23 regulatory The FDA published new guidelines allowing certain e-cigarettes and nicotine pouches onto the market without full regulatory vetting. source
- 2026-05-19 product_launch The FDA approved the first gene therapy for deafness. source
- 2026-05-18 hiring Marty Makary has departed as FDA commissioner, leading to a change in leadership at the agency. source
- 2026-05-16 hiring Dr. Tracy Beth Hoeg was removed from her role as acting director of the FDA's drug program and replaced by Dr. Mike Davis. source
- 2026-05-15 regulatory The FDA is preparing to issue alerts regarding AI hallucinations in healthcare by 2026. source
- 2026-05-15 regulatory The FDA eased restrictions on certain vaping products and reconsidered a ban on minors using tanning beds. source
- 2026-05-12 hiring US Food and Drug Commissioner Marty Makary resigned, with Kyle Diamantas stepping in as acting head. source
- 2026-05-12 hiring FDA Commissioner Marty Makary resigned after a tumultuous 13-month tenure. source
- 2026-05-12 hiring FDA Commissioner Marty Makary is stepping down after a turbulent 13-month term. source
27 day(s) with sentiment data
-
FDA Commissioner Finalists Emerge Amidst Industry Repair Efforts
The White House is narrowing down its choices for the next FDA commissioner, with three finalists reportedly being vetted. The candidates include White House aide Heidi Overton, oncologist Jeffrey Vacirca, and Pentagon …
-
New BERT Model Enhances Medical Device Recall Triage
Researchers have developed RecallRisk-BERT, a novel multi-task framework designed to improve the triage and assessment of medical device recalls. This model integrates textual data from recall narratives with structured…
-
Apple and Samsung smartwatches gain FDA-cleared sleep apnea screening features
Smartwatches from Apple and Samsung can now screen for signs of sleep apnea, a serious sleep disorder where breathing repeatedly stops. While these devices cannot diagnose the condition, they can detect breathing disrup…
-
FDA compromises with Whoop Wearable on blood pressure monitoring
The United States Food and Drug Administration (FDA) has reached a compromise with Whoop Wearable regarding blood pressure monitoring. This agreement avoids a shutdown of Whoop's blood pressure-related features, marking…
-
AI Image Firm Develops Body Scanner Without FDA Clearance
An AI image generation company, known for its visual content creation tools, is reportedly developing a body scanner. This new venture aims for a consumer rollout, but it has not yet received clearance from the FDA. The…
-
England sees zero cervical cancer deaths in young women due to HPV vaccination
For the first time, England has recorded zero deaths from cervical cancer among young women aged 20-24 over a five-year period, a significant achievement attributed to high HPV vaccination rates. A study published in Th…
-
AI/ML studies surge on ClinicalTrials.gov with limited FDA oversight
A review of studies on ClinicalTrials.gov between 2010 and 2023 revealed a significant increase in AI/ML research. Out of 3,106 studies, only 7.6% were regulated by the FDA, highlighting a gap in oversight for AI applic…
-
FDA Approves Moderna mRNA Vaccine; Logarithms Explored
The FDA has unanimously approved Moderna's mRNA vaccine, a decision that signifies a major advancement in mRNA technology and is anticipated to significantly influence the healthcare sector. Separately, the concept of l…
-
US Approves New Sunscreen Ingredient Bemotrizinol After Decades-Long European Use
The U.S. Food and Drug Administration has approved bemotrizinol, a new sunscreen ingredient, for over-the-counter use, marking the first such approval in the U.S. since 1999. This chemical sunscreen ingredient has been …
-
Public health expert Nina Schwalbe runs for Congress to boost science in government
Nina Schwalbe, a public health professional, is running for Congress to represent Manhattan's 12th Congressional District. She aims to bring a science-based perspective to government, motivated by perceived governmental…
-
AI engine identifies EU AI Act compliance as a top startup niche 23 times
An autonomous AI engine named EvoRadar, designed to discover novel startup ideas, repeatedly identified opportunities related to the EU AI Act. Across three independent iterations and varying signal sources, the engine …
-
Midjourney pivots to hardware with water scanner and spa
Midjourney, an AI image generation company, is reportedly expanding into hardware with a new ultrasonic water scanner. This device is designed to analyze water quality in 60 seconds. The company also announced plans to …
-
Longevity field's cellular reprogramming theory faces human trial reality check
A groundbreaking human trial has begun for a gene therapy aimed at partially reprogramming older cells to a younger state, a development that could validate key theories in the longevity medicine field. This early-stage…
-
AI image generator Midjourney unveils full-body ultrasonic scanner
Midjourney, primarily known for its AI image generation tools, is venturing into the medical hardware space with the development of a full-body ultrasonic scanner. This new device, named The Midjourney Scanner, aims to …
-
FDA clears second fly species for maggot therapy; ESPResSo package noted
The U.S. Food and Drug Administration (FDA) has approved a second species of fly for use in maggot wound therapy. This therapy, while lacking extensive data, is supported by proponents and includes a backup method known…
-
US faces breast biopsy needle shortage until March 2027 after Hologic recall
A shortage of breast biopsy needles is impacting cancer detection in the United States, with the Food and Drug Administration predicting the scarcity will last until March 2027. This shortage stems from a recall initiat…
-
Midjourney unveils radiation-free ultrasound body scanner and spa plans
Midjourney, known for its AI image generation tools, has unveiled a new medical imaging system called the Midjourney Scanner. This prototype device uses ultrasound technology, described as radiation-free and magnet-free…
-
Medicare expands wearable device access for health outcome data
Medicare is launching initiatives to increase access to wearable health devices for beneficiaries, aiming to gather data on health outcomes. A pilot program called ACCESS will reimburse companies for wearables and app u…
-
FDA Clears Oculogica's SNAP Eye-Tracking Concussion Test
Oculogica has received FDA clearance for its portable eye-tracking device, SNAP, designed to objectively diagnose concussions on the sidelines. The device captures involuntary eye movements, which are disrupted by concu…
-
Ningbo Yun Sheng seeks HK listing; Innovent licenses DMX-200
Ningbo Yun Sheng has submitted an application to the Hong Kong Stock Exchange for an H-share issuance and listing. Separately, Innovent Biologics has entered into an exclusive licensing agreement with Dimerix Limited to…